外周炎症标志物与凝血因子在中枢神经系统免疫性疾病及胶质瘤患者中的作用
该研究回顾性收集2018年1月至2020年12月在本机构因胶质瘤、三叉神经痛/面肌痉挛/神经鞘瘤手术及诊断为多发性硬化的患者数据,计算炎症标志物与凝血因子水平。结果显示胶质瘤患者术前NLR、D-二聚体、纤维蛋白原、抗凝血酶及因子VIII显著高于健康对照和MS组,且与胶质瘤分级正相关;ROC曲线证实NLR诊断胶质瘤的曲线下面积最大为0.8616。
要点
- 胶质瘤患者术前NLR、D-二聚体、纤维蛋白原、抗凝血酶及因子VIII显著高于健康对照和MS组。
- NLR诊断胶质瘤的曲线下面积最大为0.8616(0.8322-0.8910)。
- 淋巴细胞计数/单核细胞计数及白蛋白计数[g/L]+总淋巴细胞计数×5在胶质瘤患者中显著降低并与分级负相关。
核心结论
- 多种炎症标志物和凝血因子可作为胶质瘤诊断、分级及与多发性硬化鉴别诊断的生物标志物。
- 这些标志物的联合应用表现出高灵敏度和特异度。
研究设计与样本
- 回顾性收集2018年1月至2020年12月在本机构因胶质瘤、三叉神经痛/面肌痉挛/神经鞘瘤手术及诊断为多发性硬化的患者数据。
- 纳入健康个体155例、三叉神经痛/面肌痉挛患者64例、多发性硬化患者47例、神经鞘瘤患者316例、胶质瘤患者814例。
- 入院时采集炎症标志物和凝血因子水平,计算中性粒细胞计数/淋巴细胞计数(NLR)、(白细胞计数减中性粒细胞计数)/淋巴细胞计数、血小板计数/淋巴细胞计数、淋巴细胞计数/单核细胞计数及白蛋白计数[g/L]+总淋巴细胞计数×5。
主要发现
- 与健康对照和MS组相比,胶质瘤患者术前NLR、(白细胞计数减中性粒细胞计数)/淋巴细胞计数、D-二聚体、纤维蛋白原、抗凝血酶及因子VIII水平显著升高,且与胶质瘤分级正相关。
- 淋巴细胞计数/单核细胞计数及白蛋白计数[g/L]+总淋巴细胞计数×5在胶质瘤患者中显著降低,且与胶质瘤分级负相关。
- ROC曲线显示NLR诊断胶质瘤的曲线下面积最大为0.8616(0.8322-0.8910),其次为D-二聚体和抗凝血酶,曲线下面积分别为0.8205(0.7601-0.8809)和0.8455(0.8153-0.8758)。
- NLR和D-二聚体在MS诊断及与胶质瘤鉴别诊断中也显示出高灵敏度。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Gliomas are associated with high rates of disability and mortality, and currently, there is a lack of specific and sensitive biomarkers for diagnosis. The ideal biomarkers should be detected early through noninvasive methods. Our research aims to develop a rapid, convenient, noninvasive diagnostic method for gliomas, as well as for grading and differentiation. METHOD: We retrospectively collected data from patients who underwent surgery for glioma, trigeminal neuralgia/hemifacial spasmschwannoma, and those diagnosed with multiple sclerosis at our institution from January 2018 to December 2020. Inflammatory markers and coagulation factor levels were collected on admission, and neutrophil count (NLR), (WBC count minus neutrophil count) / lymphocyte count, platelet count / lymphocyte count, lymphocyte count / monocyte count, and albumin count [g/L] + total lymphocyte count × 5 were calculated for patients. Analyze the significance of biomarkers in the diagnosis and grading of gliomas, the diagnosis of MS, and the differential diagnosis of them. RESULTS: We evaluated 155 healthy individuals, 64 trigeminal neuralgia/hemifacial spasm patients, 47 MS patients, 316 schwannoma patients, and 814 with glioma patients. Compared with healthy controls and MS group, the preoperative levels of NLR, (WBC count minus neutrophil count) / lymphocyte count, D-dimer, Fibrinogen, Antithrobin, and Factor VIII of glioma patients were significantly higher in glioma patients and positively correlated with the grade of glioma. Conversely, 0020 lymphocyte count / Monocyte count and albumin count [g/L] + total lymphocyte count × 5 were significantly lower and negatively correlated with glioma grading. ROC curves confirmed that for the diagnosis of glioma, NLR showed a maximum area under the curve value of 0.8616 (0.8322-0.8910), followed by D-dimer and Antithrombin, with area under the curve values of 0.8205 (0.7601-0.8809) and 0.8455 (0.8153-0.8758), respectively. NLR and d-dimer also showed great sensitivity in the diagnosis of MS and differential diagnosis with gliomas. CONCLUSIONS: Our study demonstrated that multiple inflammatory markers and coagulation factors could be utilized as biomarkers for the glioma diagnosis, grading, and differential diagnosis of MS. Furthermore, the combination of these markers exhibited high sensitivity and specificity.
引用
- Huang T, Sun F, Gao K, et al. The Role of Peripheral Inflammatory Markers and Coagulation Factors in Patients with Central Nervous System (CNS) Immune Disease and Glioma. World Neurosurg. 2024. PMID: 38763458. doi:10.1016/j.wneu.2024.05.080
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。